Changes in target ability of nanoparticles due to protein corona composition and disease state

Many studies have shown the influence of protein corona (PC) on the active targeting capability of ligand-modified nanoparticles; however, the influence of clinical status on PC composition and targeting capacity is rarely discussed. In this study, when transferrin-modified PEGylated polystyrene nan...

Full description

Saved in:
Bibliographic Details
Published in:Asian journal of pharmceutical sciences 2022-05, Vol.17 (3), p.401-411
Main Authors: Xu, Wenwen, Xu, Mingyu, Xiao, Yumeng, Yu, Lu, Xie, Huiru, Jiang, Xuehua, Chen, Meiwan, Gao, Huile, Wang, Ling
Format: Article
Language:English
Subjects:
Comorbidity
Diabetes mellitus
Original Research Paper
Protein corona
Targeting capability
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Many studies have shown the influence of protein corona (PC) on the active targeting capability of ligand-modified nanoparticles; however, the influence of clinical status on PC composition and targeting capacity is rarely discussed. In this study, when transferrin-modified PEGylated polystyrene nanoparticles (Tf-PNs) is intravenously injected into mice with non-small cell lung cancer (NSCLC) comorbid with type 2 diabetes mellitus (T2DM), more Tf-PNs accumulated in the tumor tissue than in those of NSCLC model mice. This indicated that PC derived from different states of disease changed the active targeting ability of Tf-PNs. To explain the occurrence of this phenomenon, our analysis of PC from different disease states revealed that Tf (transferrin) modification had no significant effect on the formation of PC, and that the PC from the NSCLC comorbid with T2DM model contained more proteins like fibrin and clusterin. This work demonstrates the impacts of comorbidity, such as with T2DM, on the active targeting capability of ligand-modified nanoparticles, and the results promote the application of nanoparticles for precision medicine. [Display omitted]
ISSN:1818-0876
2221-285X
DOI:10.1016/j.ajps.2022.03.002